e-learning
resources
Stockholm 2007
Monday 17.09.2007
Pulmonary circulation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exercise induced pressure-flow profiles in the lung circulation have different responses in vasodilator responsive and non-responsive subjects with pulmonary hypertension (PH)
R. Syyed, A. Peacock (Glasgow, United Kingdom)
Source:
Annual Congress 2007 - Pulmonary circulation
Session:
Pulmonary circulation
Session type:
Thematic Poster Session
Number:
2101
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Syyed, A. Peacock (Glasgow, United Kingdom). Exercise induced pressure-flow profiles in the lung circulation have different responses in vasodilator responsive and non-responsive subjects with pulmonary hypertension (PH). Eur Respir J 2007; 30: Suppl. 51, 2101
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Contrasting cardiopulmonary responses to incremental exercise in patients with schistosomiasis-associated and idiopathic pulmonary arterial hypertension with similar resting hemodynamic impairment
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension
Year: 2009
Effects of hypoxia-induced chronic changes in pulmonary haemodynamics on the lung function and responsiveness in rats
Source: Annual Congress 2009 - Experimental approaches in animals and modelling in humans
Year: 2009
Improvement of exercise capacity in monocrotaline induced pulmonary hypertension by the phosphodiesterase inhibitor Vardenafil
Source: Annual Congress 2006 - Signalisation in the pulmonary vasculature: new pathways and wrong signals
Year: 2006
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Pulmonary vascular response to exercise in heart-failure patients with pulmonary hypertension: role of a pre-capillary component
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Haemodynamic effects of exercise therapy in stable, optimally treated pulmonary arterial hypertension
Source: International Congress 2017 – Exercise and physiology in pulmonary hypertension
Year: 2017
Hemodynamic effects of sildenafil in pulmonary arterial hypertension (PAH) patients
Source: Annual Congress 2005 - Treatment of pulmonary arterial hypertension
Year: 2005
Haemodynamic responses to exercise in patients with COPD
Source: Eur Respir J 2013; 41: 1031-1041
Year: 2013
Role of tadalafil in patients with hypoxia / lung disease induced (group 3) pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016
Impact of long-term oxygen therapy on systemic inflammation, morphological changes of red blood cells, pulmonary hemodynamics and diaphragm function in patients with chronic obstructive pulmonary disease.
Source: International Congress 2018 – Integrated care and non-pharmacological management of COPD
Year: 2018
Pulmonary artery pressure (PAP) reduction by systemic and inhaled nitroglycerin (NTG) in an isolated rabbit lung model of pulmonary hypertension (PH)
Source: Eur Respir J 2003; 22: Suppl. 45, 270s
Year: 2003
Acute vasodilator response in different forms of pre-capillary pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020
Identification of individuals susceptible to high-altitude pulmonary oedema at low altitude
Source: Eur Respir J 2005; 25: 545-551
Year: 2005
‘Idiopathic‘ pulmonary arterial hypertension with preserved lung function but co-existing parenchymal abnormalities: Response to treatment and survival
Source: Annual Congress 2012 - Pulmonary circulation: clinical databases and registries
Year: 2012
Pulmonary arterial pressure response during exercise in COPD patients and healthy subjects
Source: Annual Congress 2009 - Pulmonary vascular diseases
Year: 2009
Sitaxsentan for pulmonary arterial hypertension (PAH) patients with clinical deterioration or significantly abnormal liver function test on bosentan
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005
Pulmonary artery pressure (PAP) is reduced by inhaled sodium nitroprusside (SNP) in an isolated lung model of pulmonary hypertension: comparison with systemic application
Source: Eur Respir J 2002; 20: Suppl. 38, 4s
Year: 2002
Acetazolamide and chronic hypoxia: effects on haemorheology and pulmonary haemodynamics
Source: Eur Respir J 2012; 40: 1401-1409
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept